An Open-Label Single-Arm Clinical Trial to Evaluate The Efficacy of Abatacept in Moderate to Severe Patch Type Alopecia Areata
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Abatacept
Related studies linked through entity extraction aliases.
Efficacy of Ustekinumab Followed by Abatacept for the Treatment of Psoriasis Vulgaris
- Status
- COMPLETED
- Phase
- PHASE2
Abatacept to Treat Steroid Refractory Chronic Graft Versus Host Disease (cGVHD)
- Status
- COMPLETED
- Phase
- PHASE1
Bone Marrow Transplant With Abatacept for Non-Malignant Diseases
- Status
- COMPLETED
- Phase
- PHASE1
A Clinical Trial to Evaluate the Efficacy of Abatacept in Moderate to Severe Alopecia Areata
- Status
- WITHDRAWN
- Phase
- PHASE2
Study to Characterize the Pharmacokinetics of a Single Dose of SC Abatacept 125 mg Using the BD Autoinjector or the Prefilled Syringe
- Status
- COMPLETED
- Phase
- PHASE1
Efficacy and Safety of Subcutaneous Abatacept in Adults With Active Psoriatic Arthritis
- Status
- COMPLETED
- Phase
- PHASE3
Methotrexate-Inadequate Response Autoinjector Device Sub Study
- Status
- COMPLETED
- Phase
- PHASE3
Pharmacokinetics, Efficacy and Safety of Abatacept Administered Subcutaneously (SC) in Children and Adolescents With Active Polyarticular Juvenile Idiopathic Arthritis (pJIA) and Inadequate Response (IR) to Biologic or Non Biologic Disease Modifying Anti-rheumatic Drugs (DMARDs)
- Status
- COMPLETED
- Phase
- PHASE3
Efficacy, Safety, Pharmacokinetics and Immunogenicity Study of Abatacept Administered Intravenously to Treat Active Polyarticular-course Juvenile Idiopathic Arthritis in Japan
- Status
- COMPLETED
- Phase
- PHASE3
Abatacept Post-marketing Clinical Study in Japan
- Status
- COMPLETED
- Phase
- PHASE4
Abatacept as GVHD Prophylaxis Phase 2
- Status
- COMPLETED
- Phase
- PHASE2
A Pilot Study of the Safety and Efficacy of Abatacept Injections in the Treatment of Behcet's Syndrome
- Status
- COMPLETED
- Phase
- EARLY_PHASE1
Real-world Clinical Efficacy of Abatacept in the T3 Data Registry
- Status
- COMPLETED
- Phase
- N/A
Benefits of Injectable Abatacept Using Magnetic Resonance Imaging (MRI) in Rheumatoid Arthritis (RA) Patients
- Status
- COMPLETED
- Phase
- PHASE3
Efficacy at 24 Weeks and Safety, Tolerability and Long Term Efficacy of Secukinumab (AIN457) in Patients With Active Rheumatoid Arthritis (RA) and an Inadequate Response to Anti-Tumor Necrosis Factor α (Anti-TNFα) Agents (CAIN457F2309 and CAIN457F2309E1)
- Status
- COMPLETED
- Phase
- PHASE3
A Study to Assess the Receptor Occupancy of CD86 and CD80 in Subjects With Rheumatoid Arthritis Initiating Abatacept
- Status
- COMPLETED
- Phase
- N/A
Abatacept Costimulatory Blockade in the Treatment of Alopecia Totalis/Universalis
- Status
- WITHDRAWN
- Phase
- PHASE2
Ultrasound Scores as Indication of Response to Subcutaneous Abatacept in Subjects With Rheumatoid Arthritis
- Status
- COMPLETED
- Phase
- PHASE3
SWITCH Clinical Trial for Patients With Rheumatoid Arthritis Who Have Failed an Initial TNF-blocking Drug.
- Status
- COMPLETED
- Phase
- PHASE4